Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Removing both ovaries treated the woman's excess male hormone symptoms.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

A new model helps predict treatment success in girls with early puberty.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Monitoring for adverse effects in clinical treatments is crucial.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.